Synthetic Route of 1676-86-4, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 1676-86-4, Name is (S)-Benzyl (4-(2,5-dioxooxazolidin-4-yl)butyl)carbamate, molecular formula is C15H18N2O5. In a Patent£¬once mentioned of 1676-86-4
A charge conversion nano pharmaceutical composition and its preparation method (by machine translation)
The invention is applicable to the field of medical technology, provides a charge conversion nano pharmaceutical composition and its preparation method. The charge conversion nano-drug composition comprises a drug and of which the kernel, the kernel states carries the medicineoutside states the nucleus is to the conversion of the electric charge carrier lock, the kernel with the states carries the medicine through positive and negative charge of which the bound; states carries the medicine kernel of the positively charged carrier is a targeting peptide modified polyethylene glycol – hydrophobic modified chitosan, the drug is a hydrophobic drug, the load in the said carrier; said carrier lock for side chain modification 2, 3 – dimethyl maleic acid of a polylysine. The present invention provides a pharmaceutical composition of the charge conversion nano, realizes a plurality of medicine with a plurality of diagnostic and therapeutic method of the joint, thus for some tumor diseases has opened up new channels. (by machine translation)
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Synthetic Route of 1676-86-4. In my other articles, you can also check out more blogs about 1676-86-4
Reference£º
Oxazolidine – Wikipedia,
Oxazolidine | C3H2689NO – PubChem